SCHEMBL9606773

SCHEMBL9606773

CCOC(=O)c1c(C(=O)OCC)c(O)c2ccccc2c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.58
KDM4E B2RXH2 5/20 0.57
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA7 P43166 1/20 0.56
CA9 Q16790 1/20 0.56
CA14 Q9ULX7 1/20 0.56
GAA P10253 4/20 0.54
HPGD P15428 1/20 0.54
RECQL P46063 2/20 0.53
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CFTR P13569 2/20 0.50
TSHR P16473 1/20 0.50
HTT P42858 1/20 0.49
MAPT P10636 3/20 0.49
MEN1 O00255 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1590707 0.93 ALDH1A1 (0.65) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL10058490 0.91 CA12 (0.60) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL3561171 0.87 KDM4E (0.59) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL28261477 0.86 ALDH1A1 (0.61) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL30881958 0.84 CA12 (0.56) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL10305430 0.84 ALDH1A1 (0.56) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL1590855 0.83 ALDH1A1 (0.55) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL1590061 0.83 ALDH1A1 (0.55) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL27948981 0.82 ALDH1A1 (0.57) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL12002083 0.81 ALDH1A1 (0.56) ALDH1A1KDM4ECA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2457897-A1 BENZO (F) ISOINDOL-2-YLPHENYL ACETIC ACID DERIVATIVES AS EP4 RECEPTOR AGONISTS Glaxo Group Limited (GB) 2012-05-30 EP disclosed
US-8026270-B2 Benzo [F] isoindoles as EP4 receptor agonists GLAXO GROUP LIMITED (GB) 2011-09-27 US disclosed
EP-2046742-B1 BENZO [F] ISOINDOLES AS EP4 RECEPTOR AGONISTS GLAXO GROUP LTD (GB) 2010-09-22 EP disclosed
US-20090312388-A1 Benzo [F] Isoindoles As EP4 Receptor Agonists GLAXO GROUP LIMITED 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312388-A1 Benzo [F] Isoindoles As EP4 Receptor Agonists PTGER4, GPR4, PTGER1 ALDH1A1 1617/4885KDM4E 2242/4885CA12 4795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.